Drowsiness in Latuda - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Drowsiness, when it was recovered, drug effectiveness, race, and more among people who take Latuda (lurasidone hydrochloride). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Drowsiness?

Drowsiness is found to be associated with 2,866 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.



On Jul, 31, 2026

19 people who have Drowsiness while taking Latuda were studied.

Could Latuda cause Drowsiness?

Severity of Drowsiness *:

  • least: 0.0 %
  • moderate: 41.67 %
  • severe: 41.67 %
  • most severe: 16.67 %

When people recovered from Drowsiness *:

  • while on drug: 12.5 %
  • after off the drug: 0.0 %
  • not yet: 87.5 %

Effectiveness of Latuda *:

  • not at all: 0.0 %
  • somewhat: 20 %
  • moderate: 50 %
  • high: 20 %
  • very high: 10 %

Race of the people *:

  • African American, Non-Hispanic: 5.88 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 0.0 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 11.76 %
  • White, Non-Hispanic: 82.35 %

Time on Latuda *:

  • < 1 month: 14.29 %
  • 1 - 6 months: 28.57 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 21.43 %
  • 2 - 5 years: 28.57 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 7.14 %

Gender of people when taking Latuda *:

  • female: 84.21 %
  • male: 15.79 %

Age of people when taking Latuda *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10.53 %
  • 20-29: 21.05 %
  • 30-39: 26.32 %
  • 40-49: 26.32 %
  • 50-59: 5.26 %
  • 60+: 10.53 %

Conditions people have *:

  1. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 6 people, 31.58%
  2. Allergies: 2 people, 10.53%
  3. Stress And Anxiety: 2 people, 10.53%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
  5. High Blood Pressure: 2 people, 10.53%
  6. Weight Increased: 1 person, 5.26%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.26%
  8. Acne (skin problems that cause pimples): 1 person, 5.26%
  9. Adrenalitis (inflammation of one or both adrenal glands): 1 person, 5.26%
  10. Asthma: 1 person, 5.26%

Other drugs people take besides Latuda *:

  1. Vitamin D: 3 people, 15.79%
  2. Lexapro: 3 people, 15.79%
  3. Prazosin Hydrochloride: 2 people, 10.53%
  4. Wellbutrin Xl: 2 people, 10.53%
  5. Vyvanse: 2 people, 10.53%
  6. Biotin: 2 people, 10.53%
  7. Effexor Xr: 1 person, 5.26%
  8. Geodon: 1 person, 5.26%
  9. Gabapentin: 1 person, 5.26%
  10. Furosemide: 1 person, 5.26%

Other side effects people have besides Drowsiness *:

  1. Weight Increased: 3 people, 15.79%
  2. Vision Problems: 2 people, 10.53%
  3. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 10.53%
  4. Memory Loss: 2 people, 10.53%
  5. Yawning (simultaneous inhalation of air and stretching of the eardrums, followed by exhalation of breath): 1 person, 5.26%
  6. Hair Loss: 1 person, 5.26%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.26%
  8. Asthma: 1 person, 5.26%
  9. Binge Eating (pattern of disordered eating which consists of episodes of uncontrollable eating): 1 person, 5.26%
  10. Compulsive Shopping: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and have Drowsiness?

Check whether Drowsiness is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on lurasidone hydrochloride (the active ingredients of Latuda). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: